Join WhatsApp

Folow Facebook

Subscribe YouTube

Follow Instagram

New Delhi: US pharma giant Eli Lilly on Monday announced plans to invest more than $1 billion in India over the next several years for new contract manufacturing, boosting the country’s Make in India goal.

The strategic investment is expected to expand patients’ access to the company’s key medicines, including those for obesity, diabetes, Alzheimer’s, cancer, and autoimmune conditions, around the world, the company said.

Follow for more details: munsifdaily.com

“Lilly’s investment in India reflects confidence in India’s skilled talent, robust infrastructure, and business-friendly policies, while supporting Lilly’s journey as a global leader in life sciences. Together, we are shaping a stronger future for healthcare an

See Full Page